What are the treatment options for Postural Orthostatic Tachycardia Syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Postural Orthostatic Tachycardia Syndrome (POTS)

The most effective treatment for POTS involves a combination of non-pharmacological interventions including increased fluid intake (2-3 liters daily), increased salt consumption (5-10g daily), compression garments, and a structured exercise program, followed by targeted pharmacological therapy based on the specific POTS phenotype. 1

Non-Pharmacological Management

Fluid and Salt Management

  • Increase daily fluid intake to 2-3 liters per day 1
  • Increase salt consumption to 5-10g (1-2 teaspoons) of table salt daily 1
  • Avoid salt tablets to minimize gastrointestinal side effects; instead, encourage liberalized dietary sodium intake 1

Physical Countermeasures

  • Use waist-high compression garments to improve venous return 1
  • Implement physical counter-pressure maneuvers (leg-crossing, stooping, squatting, muscle tensing) during symptomatic episodes 1, 2
  • Elevate the head of the bed during sleep 1

Exercise Training

  • Begin with horizontal exercise (rowing, swimming, recumbent bike) to avoid upright posture that triggers symptoms 2
  • Progressively increase duration and intensity of exercise as fitness improves 2
  • Gradually add upright exercise as tolerated 2
  • Supervised training is preferable to maximize functional capacity 2

Pharmacological Management Based on POTS Phenotype

Hypovolemic POTS

  • Fludrocortisone can be beneficial for volume expansion 1, 3
  • Oral fluid loading has a pressor effect and may require less volume than intravenous fluid infusion 1

Neuropathic POTS

  • Midodrine (2.5-10 mg three times daily) enhances vascular tone 1, 4
    • First dose in the morning before rising and last dose no later than 4 PM to avoid supine hypertension 1
    • Monitor for supine hypertension 1, 4
    • Use with caution in older males due to potential urinary outflow issues 1
  • Pyridostigmine can be used as an alternative to enhance vascular tone 3, 5

Hyperadrenergic POTS

  • Beta-blockers (particularly propranolol) can treat resting tachycardia 1, 6
  • Avoid medications that inhibit norepinephrine reuptake 1, 6

Special Considerations

Medication Precautions

  • Carefully adjust or withdraw medications that may cause hypotension 1
  • For heart rates as high as 180 bpm, consider cardiac evaluation to rule out other arrhythmias 1
  • Monitor response to treatment by tracking standing heart rate and symptom improvement 1

Managing Associated Conditions

  • For patients with comorbid anxiety, consider:

    • Education about the physiological process of anxiety and its interaction with POTS symptoms 7
    • Teaching sensory grounding techniques 7
    • Breathing techniques and progressive muscle relaxation 7
    • For severe anxiety, SSRIs may be considered (initiated at low doses and titrated slowly) 7
  • For patients with chronic fatigue syndrome and POTS:

    • Consider coenzyme Q10 and d-ribose supplementation 1
    • Low-dose naltrexone may help with pain, fatigue, and neurological symptoms 1
    • Transcutaneous vagal stimulation may help with autonomic dysfunction 1

Important Caveats

  • Currently, there are no FDA-approved medications specifically for POTS 3, 5
  • Treatment should target the specific underlying pathophysiological mechanism 6
  • Assess treatment efficacy by monitoring both symptom improvement and reduction in standing heart rate 1, 8

References

Guideline

Treatment of Postural Orthostatic Tachycardia Syndrome (POTS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Exercise and non-pharmacological treatment of POTS.

Autonomic neuroscience : basic & clinical, 2018

Research

Pharmacotherapy for postural tachycardia syndrome.

Autonomic neuroscience : basic & clinical, 2018

Guideline

Treatment of Anxiety in Patients with Postural Orthostatic Tachycardia Syndrome (POTS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical neurophysiology of postural tachycardia syndrome.

Handbook of clinical neurology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.